Discovery of a novel dual EGFR/HER-2 inhibitor

被引：0
|
作者：
不详
机构：
来源：
PHARMACOGENOMICS | 2010年 / 11卷 / 06期
关键词：
RESISTANCE; GEFITINIB;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：745 / 745
页数：1
相关论文
共 50 条
  • [41] EGFR, HER-2 and COX-2 levels in colorectal cancer
    Antonacopoulou, A. G.
    Tsamandas, A. C.
    Petsas, T.
    Liava, A.
    Scopa, C. D.
    Papavassiliou, A. G.
    Kalofonos, H. P.
    HISTOPATHOLOGY, 2008, 53 (06) : 698 - 706
  • [42] Concordance of EGFR and HER-2 expression in invasive breast carcinoma
    Heller, J
    Bloom, KJ
    LABORATORY INVESTIGATION, 2002, 82 (01) : 37A - 37A
  • [43] Concordance of EGFR and HER-2 expression in invasive breast carcinoma
    Heller, J
    Bloom, KJ
    MODERN PATHOLOGY, 2002, 15 (01) : 37A - 37A
  • [44] EGFR and Her-2 expression and gene amplification in ovarian tumors
    Kim, H.
    Kim, A.
    Kim, H. K.
    Kim, I.
    LABORATORY INVESTIGATION, 2008, 88 : 209A - 210A
  • [45] EGFR and her-2 expression and gene amplification in ovarian tumors
    Kim, H.
    Kim, A.
    Kim, H. K.
    Kim, I.
    MODERN PATHOLOGY, 2008, 21 : 209A - 210A
  • [46] Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas
    Kountourakis, P
    Pavlakis, K
    Psyrri, A
    Rontogianni, D
    Xiros, N
    Patsouris, E
    Pectasides, D
    Economopoulos, T
    CANCER JOURNAL, 2006, 12 (03): : 229 - 236
  • [47] Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors
    Alsaid, Mansour S.
    Al-Mishari, Abdullah A.
    Soliman, Aiten M.
    Ragab, Fatma A.
    Ghorab, Mostafa M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 141 : 84 - 91
  • [48] The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38
    LaBonte, Melissa J.
    Manegold, Philipp C.
    Wilson, Peter M.
    Fazzone, Will
    Louie, Stan G.
    Lenz, Heinz-Josef
    Ladner, Robert D.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (12) : 2957 - 2969
  • [49] Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma
    Kondo, Norio
    Tsukuda, Mamoru
    Ishiguro, Yukari
    Kimura, Machiko
    Fujita, Kyoko
    Sakakibara, Atsuko
    Takahashi, Hideaki
    Toth, Gabor
    Matsuda, Hideki
    ONCOLOGY REPORTS, 2010, 23 (04) : 957 - 963
  • [50] Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells
    O'Donovan, Norma
    Byrne, Annette T.
    O'Connor, Aisling E.
    McGee, Sharon
    Gallagher, William M.
    Crown, John
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 752 - 759
12345